HENRY SCHEIN INC (HSIC): Results of Operations and Financial Condition
HENRY SCHEIN INC (HSIC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 exhibit991.htm EX-99.1 exhibit991 -1- more FOR IMMEDIATE RELEASE HENRY SCHEIN REPORTS STRONG SECOND QUARTER 2026 FINANCIAL RESULTS AND RAISES FY2026 GUIDANCE ● Q2 2026 GAAP diluted EPS of $0.82 compared to $0.70 GAAP diluted EPS in Q2 2025 ● Q2 2026 non-GAAP diluted EPS
How this was made
The 30-second read
Why it matters
Traders can update valuation and positioning based on the new FY2026 EPS and sales growth ranges, plus Q2 performance metrics (GAAP and non-GAAP EPS, net sales growth, adjusted EBITDA).
Market read
A same-day guidance raise with quantified FY2026 ranges is a direct catalyst for earnings expectations and near-term trading flows.
What to watch
The filing notes assumptions about foreign currency exchange rates remaining consistent and excludes tariff-refund benefits; deviations in FX or policy could pressure subsequent results versus the raised ranges.
Background
This is Henry Schein’s SEC Form 8-K (Item 2.02) reporting Q2 2026 results and raising FY2026 financial guidance.
Ticker impact
Henry Schein raised FY2026 guidance, including non-GAAP diluted EPS to $5.29 to $5.39 and sales growth to 4.5% to 5.5%.
Likely positive bias for HSIC as traders price in higher FY2026 EPS and EBITDA growth, with focus on whether margins and internal sales momentum persist.
The filing provides specific, updated FY2026 ranges and Q2 results (GAAP and non-GAAP EPS, net sales growth) plus the stated drivers (margin improvement, accelerated internal local currency sales).
Market effects
Supports the view that healthcare distribution and value-added services demand and margins are improving, potentially benefiting peers via read-across.
Limited direct regional signal; includes foreign currency exchange as a component of reported growth.
Moderate, as the company operates globally and guidance assumes FX stability, but the update is company-specific.
Counterpoint
The guidance raise is non-GAAP and excludes several items (restructuring, amortization, impairments, certain costs), so GAAP earnings power may be less strong than the headline implies.
Key entities
- public_companyHenry Schein, Inc.
Healthcare solutions provider reporting Q2 2026 results and raising FY2026 guidance.
- executiveFred Lowery
CEO quoted describing margin improvement and momentum behind the guidance raise.
